A novel nutraceutical is an effective, well-tolerated therapy for the treatment of women with mild to moderate non-nodulocystic acne.

Denifanstat met all primary and secondary endpoints versus placebo Denifanstat was well tolerated Oral FASN inhibitors offer a novel mechanism of action for the potential treatment of moderate to ...

A new study published in the Journal of Drugs in Dermatology showed that while maintaining the integrity of the skin barrier, ...

Denifanstat met all primary and secondary endpoints versus placebo Denifanstat was well tolerated Oral FASN inhibitors offer a novel mechanism of action for the potential treatment of moderate to ...

Sagimet Bioscience’s denifanstat, a one-daily pill for the treatment of acne, has succeeded in a Phase III trial, with the biotech’s license partner Ascletis Bioscience set to submit the drug ...

Potential Positives. Denifanstat met all primary and secondary endpoints in a Phase 3 clinical trial, demonstrating its efficacy for the treatment of moderate to severe acne vulgaris.

Black seed oil has been used as a natural remedy for centuries, even deriving inferences in several ancient Greek, Egyptian, Indian, and Arabian texts and healing traditions.It comes from Nigella ...

The Phase III trial, conducted by Chinese license partner Ascletis, produced strong results for denifanstat compared to potential rivals.

The cause of acne vulgaris is multifactorial and often requires multiple products to obtain optimum results. Clinicians should consider using a topical retinoid for first-line management for acne ...

Acne vulgaris: Diagnosis and treatment. Am Fam Physician. 2019;100(8):475-484. MedlinePlus. Benzoyl peroxide topical. MyHealth Alberta. Acne: Treatment with benzoyl peroxide. American Academy of ...